Multiple Sclerosis Clinical Trial

Clinical Trial Finder Multiple Sclerosis Trials

A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

See Locations Near You

Summary

The purpose of this study is to compare biomarker levels in Multiple Sclerosis (MS) patients before and after beginning Natalizumab.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of clinically definite relapsing remitting MS (RRMS)
Age 45 years and older
Willing and able to provide written informed consent
Patient has high disease activity.
Patient is about to begin Natalizumab (Tysabri) therapy.

Exclusion Criteria:

Any clinically significant disease other than MS that is likely to interfere with the evaluation of CDMS
Known infectious or hematological disease.
Unwilling or unable to comply with the requirements of this protocol
Subject can not have a gadolinium enhanced MRI

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

15

Study ID:

NCT01541618

Recruitment Status:

Completed

Sponsor:

MSDx, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Northwest NeuroSpecialists, PLLC
Tucson Arizona, 85741, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

15

Study ID:

NCT01541618

Recruitment Status:

Completed

Sponsor:


MSDx, Inc.

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider